Moderna to ask the FDA to greenlight its coronavirus vaccine [View all]
Source: Washington Post

Biotechnology company Moderna, one of the leaders in the race for a coronavirus vaccine, announced it would file Monday for regulatory clearance a critical milestone that brings the United States a step closer to having two coronavirus vaccines before the end of the year.
Modernas vaccine was 94 percent effective at preventing illness in a 30,000-person clinical trial, the company said a performance that exceeds expectations and is on par with the best childhood vaccines. All 30 cases of severe covid-19, the illness caused by the virus, were in a group that received a placebo.
The application will arrive as public health experts gird for a blitz of coronavirus cases seeded by holiday travels and gatherings a surge coming so soon that no vaccine can blunt it. But Modernas filing marks the fourth Monday in a row with good news about the vaccine effort and means the United States could have enough vaccine to treat 20 million people by years end, between doses of Modernas vaccine and those of another candidate that is about a week ahead from Pfizer and German firm BioNTech. The Food and Drug Administration could authorize the vaccines for emergency use by mid- to late December.
You dont want to get ahead of yourself and claim any victories, but this has the makings of a very, very important positive impact on ending this outbreak, said Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases. A vaccine that is highly efficacious, if taken by a very, very high percentage of people, could potentially crush this outbreak similar to what was done with outbreaks of measles and polio and smallpox and other diseases.
Read more: https://www.washingtonpost.com/health/2020/11/30/moderna-covid-vaccine-fda-approval/